financetom
Business
financetom
/
Business
/
Krispy Kreme's Partnership With McDonald's to Serve as Catalyst for Expansion, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Krispy Kreme's Partnership With McDonald's to Serve as Catalyst for Expansion, Morgan Stanley Says
Nov 7, 2024 9:19 PM

11:57 AM EST, 11/05/2024 (MT Newswires) -- Krispy Kreme's (DNUT) expanded US partnership with McDonald's (MCD) is expected to serve as a catalyst that will support the former's expansion strategy, Morgan Stanley said in a Tuesday note.

The expanded partnership was announced in May, with the companies targeting a phased market rollout that will bring Krispy Kreme's most popular doughnuts to participating McDonald's branches by the end of 2026.

According to Morgan Stanley, the partnership could accelerate Krispy Kreme's "delivered fresh daily" or DFD door expansion, adding about 12,000 McDonald's locations to the network through 2026. The investment firm estimated that an addition of 1bout 14,000 DFD doors by the end of 2026 would add approximately $270 million of DFD revenue that year and $370 million in 2027.

Morgan Stanley also noted potential risks associated to the planned expansion, such as the expenses and investments to support the DFD growth and the possibility of "underwhelming" results from the McDonald's partnership.

Morgan Stanley resumed coverage on Krispy Kreme, with an equal-weight rating and a $14 price target.

Price: 11.86, Change: +0.04, Percent Change: +0.30

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AstraZeneca holds forecasts as cancer, heart drugs lift earnings
AstraZeneca holds forecasts as cancer, heart drugs lift earnings
Nov 6, 2025
(Reuters) -AstraZeneca ( AZN ) beat expectations for third quarter earnings on Thursday with strong sales of its blockbuster cancer and cardiovascular drugs, but disappointed some investors by not raising its full-year forecasts. The Anglo-Swedish drugmaker is looking to new launches, including a blood pressure drug, to offset patent expiries for medicines such as diabetes and heart treatment Farxiga as...
BillionToOne Prices $273.1 Million Upsized Initial Public Offering
BillionToOne Prices $273.1 Million Upsized Initial Public Offering
Nov 6, 2025
05:49 AM EST, 11/06/2025 (MT Newswires) -- BillionToOne ( BLLN ) said Wednesday it priced its upsized initial public offering of almost 4.6 million class A shares at $60 each, for about $273.1 million in expected gross proceeds. Underwriters have a 30-day option to purchase up to 682,665 additional shares, the company said. The shares are expected to begin trading...
Deutsche Boerse and Nasdaq targeted in EU cartel probe
Deutsche Boerse and Nasdaq targeted in EU cartel probe
Nov 6, 2025
BRUSSELS, Nov 6 (Reuters) - The European Commission on Thursday said it had opened an antitrust investigation against stock exchange companies Deutsche Boerse and Nasdaq . The Commission said it suspected the companies of breaking EU competition rules in the sector for listing, trading and clearing of financial derivatives. Deutsche Boerse and Nasdaq entities may have entered into agreements or...
Pulsar Helium Unveils Warrant Exercise by Shareholder ABCrescent Cooperatief
Pulsar Helium Unveils Warrant Exercise by Shareholder ABCrescent Cooperatief
Nov 6, 2025
05:37 AM EST, 11/06/2025 (MT Newswires) -- Pulsar Helium ( PSRHF ) said that 15.5 million warrants held by major shareholder ABCrescent Cooperatief were exercised at C$0.36, raising a total of $5.6 million. The funding will be used to advance Pulsar's flagship Topaz helium project in Minnesota. The share purchase warrants were issued to ABC as part of a unit...
Copyright 2023-2026 - www.financetom.com All Rights Reserved